OmniAb Inc has a consensus price target of $9.67 based on the ratings of 9 analysts. The high is $13 issued by Credit Suisse on December 16, 2022. The low is $6 issued by SVB Leerink on November 29, 2022. The 3 most-recent analyst ratings were released by Benchmark, Truist Securities, and Benchmark on May 14, 2024, March 26, 2024, and March 22, 2024, respectively. With an average price target of $8.67 between Benchmark, Truist Securities, and Benchmark, there's an implied 81.69% upside for OmniAb Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/14/2024 | Buy Now | 67.71% | Benchmark | Robert Wasserman | → $8 | Reiterates | Buy → Buy | Get Alert |
03/26/2024 | Buy Now | 109.64% | Truist Securities | Robyn Karnauskas | → $10 | Maintains | Buy | Get Alert |
03/22/2024 | Buy Now | 67.71% | Benchmark | Robert Wasserman | → $8 | Reiterates | Buy → Buy | Get Alert |
03/21/2024 | Buy Now | 130.61% | HC Wainwright & Co. | Joseph Pantginis | → $11 | Reiterates | Buy → Buy | Get Alert |
03/21/2024 | Buy Now | 46.75% | RBC Capital | Conor McNamara | → $7 | Reiterates | Outperform → Outperform | Get Alert |
11/14/2023 | Buy Now | 67.71% | Benchmark | Robert Wasserman | → $8 | Reiterates | Buy → Buy | Get Alert |
08/11/2023 | Buy Now | 130.61% | HC Wainwright & Co. | Joseph Pantginis | → $11 | Reiterates | Buy → Buy | Get Alert |
05/12/2023 | Buy Now | 67.71% | Benchmark | Robert Wasserman | → $8 | Reiterates | Buy → Buy | Get Alert |
04/21/2023 | Buy Now | 67.71% | Benchmark | Robert Wasserman | → $8 | Initiates | → Buy | Get Alert |
04/13/2023 | Buy Now | 109.64% | Craig-Hallum | Matt Hewitt | → $10 | Initiates | → Buy | Get Alert |
03/31/2023 | Buy Now | 130.61% | HC Wainwright & Co. | Joseph Pantginis | → $11 | Reiterates | → Buy | Get Alert |
02/22/2023 | Buy Now | 109.64% | Cowen & Co. | Steven Mah | → $10 | Initiates | → Outperform | Get Alert |
02/13/2023 | Buy Now | 130.61% | HC Wainwright & Co. | Joseph Pantginis | → $11 | Initiates | → Buy | Get Alert |
12/20/2022 | Buy Now | 109.64% | Truist Securities | Robyn Karnauskas | → $10 | Initiates | → Buy | Get Alert |
12/16/2022 | Buy Now | 172.54% | Credit Suisse | Tiago Fauth | → $13 | Initiates | → Outperform | Get Alert |
11/29/2022 | Buy Now | 25.79% | SVB Leerink | Puneet Souda | → $6 | Initiates | → Outperform | Get Alert |
11/28/2022 | Buy Now | 151.57% | Stifel | Stephen Willey | → $12 | Initiates | → Buy | Get Alert |
The latest price target for OmniAb (NASDAQ:OABI) was reported by Benchmark on May 14, 2024. The analyst firm set a price target for $8.00 expecting OABI to rise to within 12 months (a possible 67.71% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for OmniAb (NASDAQ:OABI) was provided by Benchmark, and OmniAb reiterated their buy rating.
There is no last upgrade for OmniAb
There is no last downgrade for OmniAb.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OmniAb, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OmniAb was filed on May 14, 2024 so you should expect the next rating to be made available sometime around May 14, 2025.
While ratings are subjective and will change, the latest OmniAb (OABI) rating was a reiterated with a price target of $8.00 to $8.00. The current price OmniAb (OABI) is trading at is $4.77, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.